
ARR beat and capex hike flag demand; EBITDA breakeven H2; large-deal visibility remains limited.
Disclaimer: The content provided in this newsletter is for informational purposes only and does not constitute investment advice. We are not registered investment advisors, and nothing in this newsletter should be construed as a recommendation to buy or sell any securities. Always do your own research and consult with a licensed financial professional before making any investment decisions.
Overall, the business appears to be steadily getting back on track.
Revenue
- Q1 FY25 ARR reached $249M, ahead of the $220M guide. April ARR already hit $310M, indicating sequential acceleration in demand, with May tracking strong as well.

- FY25 revenue guidance remains unchanged at $500–700M, with ARR projected at $750–1,000M.
This report is available to subscribers. Sign in or subscribe to read the full analysis.